The patient successfully recovered after surgery, however, pathology revealed a discordant grade 3 nonfunctional neuroendocrine tumor with lymph nodes invasion. Conclusions: Surgery is the treatment of choice for pancreatic neuroendocrine neoplasms, however, when they are advanced, clinical treatment is usually given before planning surgery. In this case, we suspected of a low-grade tumor that could be cured by surgery. However final pathology showed us a completely different scenario, making us involved in a dark zone in the literature, of how to manage these patients after the procedure.
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This case enlights us since it is unclear, on whether the primary tumor should have been removed in this clinical scenario, however, we couldn't have known this if we hadn't done the surgery, and teaches us that even in a successful recovery, surgery should not have been the best choice for this kind of tumors.
EP02C-019
A PREOPERATIVE NOMOGRAM PREDICTS PROGNOSIS OF UP FRONT RESECTABLE PATIENTS WITH PANCREATIC HEAD CANCER AND SUSPECTED VENOUS INVASION Y. Shen 1 , X. Bai 2 and T. Liang 2 1 Department of Hepatobiliary and Pancreatic Surgery, Zhejiang University, and 2 Zhejiang University, China Background: Pancreatic head adenocarcinoma is commonly diagnosed at an advanced stage when adjacent vascular invasion is present. This study aimed to establish a preoperative prognostic nomogram for patients who underwent attempted curative resectional surgery for pancreatic head cancer with suspected peripancreatic venous invasion. Methods: The data on all consecutive patients who underwent attempted curative resectional surgery for pancreatic head cancer with suspected peripancreatic venous invasion were retrospectively collected from 2012 to 2016 at 4 academic institutions in China. The demographic and radiological parameters were analyzed using univariate and multivariate Cox regression analyses. The final nomogram was established using the concordance Harrell's C-indices and calibration curves from data obtained in 3 institutions and validated in the cohort of patients coming from the fourth institution. Results: The nomogram was constructed using data from 178 patients while the validation cohort consisted of 61 patients. Seven imaging features on computed tomography showing peripancreatic venous abnormalities were identified and they were classified into 4 types. Age, length of tumor contact, peripancreatic venous abnormalities and Lymph node staging were independent factors of overall survival. The nomogram showed good probabilities of survival on calibration curves. The C-index of the model in predicting overall survival (OS) was 0.824 for the validation cohort. The correlation between the radiographic and pathologic findings was high. Conclusions: The nomogram accurately predicted OS in patients with pancreatic head cancer with suspected peripancreatic venous invasion after attempted curative pancreatic resectional surgery. Modern strategies including immunotherapy show minimal efficacy in human PC. One way to improve response to immunotherapy is to reprogram the tumor microenvironment which includes desmoplastic-stroma and abundant immunosuppressive myeloid-infiltrate. We utilize a novel strategy of hyper-activating CD11b-receptor using a small molecule agonist, ADH-503. ADH-503 binds to CD11b-receptor, preventing its binding to ligand ICAM-1 which prevents leukocyte trans-endothelial migration. We hypothesize that CD11b hyper-activation will reprogram myeloid response and improve immunotherapeutic efficacy in PC. Methods: We utilized genetic (KPC: p48-Cre; LSL-KrasG12D; Trp53flox/flox) and orthotopic models of murine PC models to evaluate the effect of ADH-503 on tumorgrowth and immune-infiltrates by flow-cytometry and immunohistochemistry. Results: To determine the effect of CD11b hyper-activation in PC, we treated tumor bearing mice with ADH-503 for 10 days and observed significant reduction in tumorweight. Analysis of myeloid cells showed that monocytes, granulocytes and macrophages were significantly reduced by ADH-503. Simultaneously there was a decrease in regulatory T-cells and increase in CD8 + T-cell numbers, activation and proliferation. We observed a significant change in gene expression profiles of tumor infiltrating macrophages with ADH-503-therapy, suggesting macrophage re-polarization. In orthotopic models, which are extremely resistant to immunotherapy, combination of ADH-503+/-anti-PD1 and ADH-503+/-41BB, showed significant regression of tumor-growth, suggesting improved efficacy in combination with immunotherapy.
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